Topological barrier to Cas12a activation by circular DNA nanostructures facilitates autocatalysis and transforms DNA/RNA sensing

Fei Deng,Yi Li,Biyao Yang,Rui Sang,Wei Deng,Maya Kansara,Frank Lin,Subotheni Thavaneswaran,David M. Thomas,Ewa M. Goldys

DOI: https://doi.org/10.1038/s41467-024-46001-8

IF: 16.6

2024-03-05

Nature Communications

Abstract:Abstract Control of CRISPR/Cas12a trans -cleavage is crucial for biosensor development. Here, we show that small circular DNA nanostructures which partially match guide RNA sequences only minimally activate Cas12a ribonucleoproteins. However, linearizing these structures restores activation. Building on this finding, an Autocatalytic Cas12a Circular DNA Amplification Reaction (AutoCAR) system is established which allows a single nucleic acid target to activate multiple ribonucleoproteins, and greatly increases the achievable reporter cleavage rates per target. A rate-equation-based model explains the observed near-exponential rate trends. Autocatalysis is also sustained with DNA nanostructures modified with fluorophore-quencher pairs achieving 1 aM level (<1 copy/μL) DNA detection (10 6 times improvement), without additional amplification, within 15 min, at room temperature. The detection range is tuneable, spanning 3 to 11 orders of magnitude. We demonstrate 1 aM level detection of SNP mutations in circulating tumor DNA from blood plasma, genomic DNA ( H. Pylori ) and RNA (SARS-CoV-2) without reverse transcription as well as colorimetric lateral flow tests of cancer mutations with ~100 aM sensitivity.

multidisciplinary sciences

What problem does this paper attempt to address?

### The Problem the Paper Aims to Solve

The paper aims to address the limitations of the CRISPR/Cas12a system in molecular diagnostics, particularly its insufficient sensitivity due to the low trans-cleavage rate. Specifically, Cas12a, once activated, can non-specifically cleave single-stranded DNA (ssDNA), but its cleavage rate is relatively low (0.07 to 7 cuts/second), making it challenging to achieve clinically relevant sensitivity detection (<pM) without additional signal amplification strategies. Furthermore, the cleavage rate of Cas12a for RNA targets is also low, limiting its ability to directly detect RNA.

To overcome these limitations, researchers have discovered a specially designed small circular DNA nanostructure (referred to as Cir-mediator) that can partially match the guide RNA (gRNA) sequence and, once linearized, can activate Cas12a ribonucleoprotein (RNP). Based on this discovery, they established a self-catalytic Cas12a circular DNA amplification reaction (AutoCAR) system, allowing a single nucleic acid target to activate multiple Cas12a RNPs, significantly increasing the cleavage rate of reporter molecules. Through a self-catalytic mechanism, this system can achieve high-sensitivity detection at the 1 aM (<1 copy/μL) level at room temperature without the need for additional signal amplification steps.

In summary, the goal of the paper is to develop a new CRISPR/Cas12a self-catalytic system to enhance sensitivity and speed in molecular diagnostics, thereby achieving low-cost, high-sensitivity nucleic acid detection in clinical applications.